Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Treasury Stock, Common	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Stockholders equity, Beginning balance at Dec. 31, 2021	$ 2	$ 195,881			$ (55,186)	$ 140,697
Stockholders equity, Beginning balance (in shares) at Dec. 31, 2021	23,205,915
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock		2				2
Vesting of restricted common stock (in shares)	3,946
Issuance of common stock upon stock option exercises		19				$ 19
Issuance of common stock upon stock option exercises (in shares)	44,105					44,105
Stock-based compensation		627				$ 627
Unrealized gain (loss) on marketable securities				$ (204)		(204)
Net loss					(17,275)	(17,275)
Stockholders equity, Ending balance at Mar. 31, 2022	$ 2	196,529		(204)	(72,461)	123,866
Stockholders equity, Ending balance (in shares) at Mar. 31, 2022	23,253,966
Stockholders equity, Beginning balance at Dec. 31, 2022	$ 2	199,492	$ (35)	(161)	(150,266)	49,032
Stockholders equity, Beginning balance (in shares) at Dec. 31, 2022	23,312,529
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock		1				1
Vesting of restricted common stock (in shares)	3,946
Issuance of common stock upon stock option exercises		228				$ 228
Issuance of common stock upon stock option exercises (in shares)	462,073					462,073
Stock-based compensation		1,464				$ 1,464
Common stock repurchase			(12)			(12)
Common stock repurchase (in shares)	7,789
Unrealized gain (loss) on marketable securities				110		110
Net loss					(17,059)	(17,059)
Stockholders equity, Ending balance at Mar. 31, 2023	$ 2	$ 201,185	$ (47)	$ (51)	$ (167,325)	$ 33,764
Stockholders equity, Ending balance (in shares) at Mar. 31, 2023	23,786,337